Drug administration control method and system

Abstract

The present application provides a drug administration control method and system, which relates to the field of medical device control, wherein the method includes: sending a target drug administration instruction to an electronic analgesic pump to instruct the electronic analgesic pump to configure target drug administration parameters according to the target drug administration instruction; when the electronic analgesic pump administers drugs to a target patient according to the target drug administration parameters, recording drug administration information, and sending an information collection instruction to a smart wearable device at the start of drug administration to instruct the smart wearable device to collect the body parameter information of the target patient; detecting whether there is an abnormality in drug administration based on the current drug administration parameter information and the current body parameter information, and when it is determined that there is an abnormality in drug administration, controlling the electronic analgesic pump to stop administering drugs to the target patient, and the current drug administration parameter information is the drug administration parameter information corresponding to the current moment. The implementation of the technical solution provided by the present application solves the technical problem of low drug administration control efficiency existing in the related art.

Description

Technical Field

[0001] The present application relates to the field of medical device control, and in particular to a drug administration control method and system. Background Art

[0002] Many patients need drug treatment after diagnosis. At present, medical staff mainly administer drugs according to doctor's prescriptions. Taking anesthetic medication as an example, narcotic analgesics are often used during anesthesia to relieve patients' pain and assist in treatment. In practice, it is found that current narcotic analgesics rely on medical staff to manually control the infusion volume and duration, and require manual timely detection and response to abnormal events during medication (such as blood outflow from patients, drug infusion blockage, etc.). However, with the continuous growth of the number of patients, this method of manual medication control and handling of abnormal medication events has the problems of low intelligence and low control efficiency.

[0003] With respect to the technical problem of low drug administration control efficiency existing in the related technologies, no effective solution has been proposed so far. Summary of the invention

[0004] The present application provides a medication control method and system to at least solve the technical problem of low medication control efficiency existing in the related art.

[0005] In a first aspect, the present application provides a drug administration control method, comprising: sending a target drug administration instruction to an electronic analgesia pump to instruct the electronic analgesia pump to configure target drug administration parameters according to the target drug administration instruction; when the electronic analgesia pump administers drugs to a target patient according to the target drug administration parameters, recording drug administration information, and sending an information collection instruction to a smart wearable device at the start of drug administration to instruct the smart wearable device to collect body parameter information of the target patient, wherein the target patient wears the smart wearable device, and the drug administration information includes drug administration parameter information corresponding to multiple moments, and the multiple moments include the start of drug administration moment; detecting whether there is an abnormality in drug administration according to current drug administration parameter information and current body parameter information, and when it is determined that there is an abnormality in drug administration, controlling the electronic analgesia pump to stop administering drugs to the target patient, wherein the current drug administration parameter information is the drug administration parameter information included in the drug administration information and corresponding to the current moment, the current moment is any one of the multiple moments, and the current body parameter information is used to represent the body parameter information collected by the smart wearable device at the current moment.

[0006] By adopting the above technical solution, a target drug administration instruction is sent to the electronic analgesic pump, and the electronic analgesic pump configures the target drug administration parameters according to the target drug administration instruction. In the process of administering drugs to the target patient according to the target drug administration parameters, the electronic analgesic pump records the drug administration information, that is, records the drug administration parameter information corresponding to different times, and sends an information collection instruction to the smart wearable device at the start of drug administration, so that the smart wearable device can collect the body parameter information of the target patient, and then detect whether there is an abnormality in the drug administration of the electronic analgesic pump according to the current drug administration parameter information and the current body parameter information. When it is determined that there is an abnormality, the electronic analgesic pump is controlled to stop administering drugs to the target patient. The purpose of real-time monitoring of drug administration parameter information is achieved, and timely judgment of whether there is an abnormality in drug administration is made in combination with the body parameter information of the target patient, and the purpose of timely stopping drug administration is achieved when it is determined that there is an abnormality, avoiding the need for manual control of drug administration and the need to rely on manual labor to discover whether there is an abnormality in drug use in the related technology, resulting in low intelligence and inability to detect abnormalities in time. Therefore, the technical problem of low efficiency of drug administration control existing in the related technology is solved, and the effect of improving the efficiency of drug administration control is achieved.

[0007] Optionally, detecting whether there is an abnormality in medication based on current medication parameter information and current body parameter information includes: judging whether the current medication parameter information matches the current body parameter information based on a preset standard parameter mapping table, wherein the standard parameter mapping table records the correspondence between the medication parameters and the body parameter reference ranges; when it is judged that the current medication parameter information does not match the current body parameter information, determining that there is an abnormality in medication; when it is judged that the current medication parameter information matches the current body parameter information, determining that there is no abnormality in medication.

[0008] By adopting the above technical solution, the corresponding relationship between the medication parameters and the reference range of the body parameters is recorded in the preset standard parameter mapping table. According to the standard parameter mapping table, it is judged whether the current medication parameter information matches the current body parameter information. When it is judged that they match, it is determined that there is no abnormality in the medication. On the contrary, when it is judged that they do not match, it is determined that there is an abnormality in the medication. The purpose of automatically judging whether there is an abnormality in the current medication situation based on the preset standard parameter mapping table is achieved.

[0009] Optionally, after determining that there is an abnormality in the medication, the method further includes: determining a target category to which the abnormality belongs based on current medication parameter information and current body parameter information.

[0010] By adopting the above technical solution, after determining that there is an abnormality in medication, further, the target category to which the abnormality belongs can be determined based on the current medication parameter information and the current body parameter information, that is, the specific abnormality category can be determined.

[0011] Optionally, determining a target category to which the abnormality belongs based on current medication parameter information and current body parameter information includes: inputting the current medication parameter information and the current body parameter information into a pre-trained anomaly detection model to obtain a target category, wherein the anomaly detection model is obtained in the following manner: training an original neural network model using a sample data packet set until a loss value between a predicted sample result output by the original neural network model and a predetermined actual sample result satisfies a preset convergence condition, terminating the training, and determining the original neural network model at the end of the training as an anomaly detection model, wherein each sample data packet in the sample data packet set includes medication parameter sample data and body parameter sample data, and the actual sample results corresponding to each sample data packet in the sample data packet set are used to represent the abnormal category of the sample data packet.

[0012] By adopting the above technical solution, the current medication parameter information and the current body parameter information are detected using a pre-trained anomaly detection model to obtain a target category. The anomaly detection model is obtained by training the original neural network model using a sample data packet set, and the sample data packet set may include historical medication data and patient body parameter data. The purpose of using the anomaly detection model to detect the target category to which the anomaly belongs is achieved, so that medical staff can handle the anomaly in a timely and effective manner.

[0013] Optionally, judging whether the current medication parameter information matches the current body parameter information is based on a preset standard parameter mapping table, including: determining a body parameter reference range corresponding to the current medication parameter information in the standard parameter mapping table; when the current body parameter information falls within the body parameter reference range, judging that the current medication parameter information matches the current body parameter information; when the current body parameter information does not fall within the body parameter reference range, judging that the current medication parameter information does not match the current body parameter information.

[0014] By adopting the above technical solution, the body parameter reference range corresponding to the current medication parameter information is determined in the standard parameter mapping table. If the current body parameter information belongs to the body parameter reference range, it is judged that the current medication parameter information matches the current body parameter information. If the current body parameter information does not belong to the body parameter reference range, it is judged that the current medication parameter information does not match the current body parameter information. The purpose of judging whether the current medication parameter information matches the current body parameter information based on the preset standard parameter mapping table is achieved.

[0015] Optionally, when it is determined that there is an abnormality in the drug administration, the electronic analgesia pump is controlled to stop administering the drug to the target patient, including: when it is determined that there is an abnormality in the drug administration, a stop drug administration instruction is sent to the electronic analgesia pump to instruct the electronic analgesia pump to stop administering the drug to the target patient, and an alarm message is issued.

[0016] By adopting the above technical solution, when it is determined that there is an abnormality in the drug administration of the electronic analgesic pump, a stop drug administration instruction is sent to the electronic analgesic pump to control the electronic analgesic pump to stop administering the drug to the target patient and issue an alarm message. That is, when an abnormality occurs, the drug administration can be automatically stopped in time and an alarm can be issued.

[0017] Optionally, the above method also includes: recording the stop time information when the electronic analgesia pump stops administering medication to the target patient, wherein when the amount injected by the electronic analgesia pump is greater than or equal to the preset total medication amount, the medication to the target patient is automatically stopped; and sending a stop collection instruction to the smart wearable device at the time corresponding to the stop time information to instruct the smart wearable device to stop collecting the target patient's physical parameter information.

[0018] By adopting the above technical solution, when the amount of medicine injected by the electronic analgesic pump is greater than or equal to the preset total amount of medicine administered, it will automatically stop administering medicine to the target patient. The amount of medicine injected refers to the amount of medicine currently injected to the target patient. At this time, the stop time information is recorded, and a stop collection instruction is sent to the smart wearable device at that time, that is, the smart wearable device is notified to stop collecting the physical parameter information of the target patient.

[0019] Optionally, before sending the target drug administration instruction to the electronic analgesia pump, the above method also includes: receiving a target pre-schedule to control the electronic analgesia pump to administer the drug according to the target pre-schedule, wherein the target pre-schedule includes the drug administration period, the start drug administration time, the stop drug administration time, the preset total drug administration amount, and the drug administration duration.

[0020] By adopting the above technical solution, a target pre-schedule is received, and the electronic analgesia pump is controlled to administer medication based on the target pre-schedule. The target pre-schedule includes medication time period, medication start time, medication stop time, preset total medication amount, and medication duration. That is, a target medication instruction is issued to the electronic analgesia pump based on the target pre-schedule.

[0021] In the second aspect of the present application, a drug administration control system is also provided, including: a control terminal, an electronic analgesia pump, and an intelligent wearable device, wherein the control terminal is respectively connected to the electronic analgesia pump and the intelligent wearable device for communication; the control terminal is used to send a target drug administration instruction to the electronic analgesia pump to instruct the electronic analgesia pump to configure the target drug administration parameters according to the target drug administration instruction; the electronic analgesia pump is used to respond to the target drug administration instruction issued by the control terminal, and control the drug administration to the target patient according to the target drug administration instruction; the control terminal is also used to record the drug administration information when the electronic analgesia pump administers the drug to the target patient according to the target drug administration parameters, and send an information collection instruction to the intelligent wearable device at the start of drug administration to instruct the intelligent wearable device to collect the physical parameter information of the target patient, wherein the target patient wears A smart wearable device is worn, and the medication information includes medication parameter information corresponding to multiple moments, and the multiple moments include a starting medication moment; the smart wearable device is used to respond to an information collection instruction issued by a control terminal, collect body parameter information of a target patient, and send the body parameter information to the control terminal; the control terminal is also used to detect whether there is an abnormality in medication according to the current medication parameter information and the current body parameter information, and when it is determined that there is an abnormality in medication, control the electronic analgesia pump to stop medication to the target patient, wherein the current medication parameter information is the medication parameter information included in the medication information and corresponding to the current moment, the current moment is any one of the multiple moments, and the current body parameter information is used to indicate the body parameter information collected by the smart wearable device at the current moment.

[0022] By adopting the above technical solution, the control terminal sends a target medication instruction to the electronic analgesic pump, and the electronic analgesic pump configures the target medication parameters according to the target medication instruction. When the electronic analgesic pump administers medication to the target patient according to the target medication parameters, the control terminal also obtains and records medication information, and can obtain medication information at multiple times or in real time; the control terminal also sends an information collection instruction to the smart wearable device at the start of medication, so that the smart wearable device can collect the body parameter information of the target patient and transmit the body parameter information to the control terminal; in this way, the control terminal can detect whether there is an abnormality in medication according to the current medication parameter information and the current body parameter information, and control the electronic analgesic pump to stop medication when it is determined that there is an abnormality. The purpose of real-time monitoring of medication parameter information is achieved, and timely judgment of whether there is an abnormality in medication is made in combination with the body parameter information of the target patient, and the purpose of timely stopping medication is achieved when it is determined that there is an abnormality, avoiding the need for manual control of medication and the need to rely on manual labor to discover whether there is an abnormality in medication in the related technology, resulting in low intelligence and failure to detect abnormalities in time. Therefore, the technical problem of low efficiency of medication control in the related technology is solved, and the effect of improving the efficiency of medication control is achieved.

[0023] Optionally, upon receiving an adjustment instruction, the electronic analgesia pump adjusts the target drug administration parameters to obtain adjusted target drug administration parameters, and controls drug administration to the target patient according to the adjusted target drug administration parameters.

[0024] By adopting the above technical solution, the electronic analgesic pump can also adjust the target drug administration parameters according to the adjustment instructions, and administer the drug to the target patient according to the adjusted target drug administration parameters, thus achieving the purpose of flexibly adjusting the drug administration according to the actual needs of different patients.

[0025] In a third aspect of the present application, an electronic device is provided, including a memory and a processor, wherein a computer program is stored in the memory, and when the processor executes the program, any of the above method steps is implemented.

[0026] In a fourth aspect of the present application, a computer-readable storage medium is provided, wherein the computer-readable storage medium stores instructions, and when the instructions are executed, any of the above method steps is performed.

[0027] In summary, one or more technical solutions provided in the embodiments of the present application have at least the following technical effects or advantages:

[0028] 1. The purpose of real-time monitoring of medication parameter information is achieved, and whether there is any abnormality in medication is determined in time in combination with the physical parameter information of the target patient, and the purpose of stopping medication in time when an abnormality is determined is achieved, thereby avoiding the need for manual control of medication and the need to rely on manual labor to discover whether there is any abnormality in medication in related technologies, resulting in low intelligence and inability to detect abnormalities in time. Therefore, the technical problem of low efficiency of medication control in related technologies is solved, and the effect of improving the efficiency of medication control is achieved.

[0029] 2. After determining that there is an abnormality in drug administration, the target category to which the abnormality belongs can be further determined, so that medical staff can handle the abnormality in a timely and effective manner.

[0030] 3. When an abnormality occurs, the drug administration can be automatically stopped and an alarm can be issued in time; and the drug administration can be flexibly adjusted according to the actual needs of different patients. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 is a flow chart of a drug administration control method provided in an embodiment of the present application;

[0032] Figure 2 This is an example diagram of an application scenario of drug administration control provided in an embodiment of the present application;

[0033] Figure 3 This is a framework diagram of a drug administration control system provided in an embodiment of the present application;

[0034] Figure 4 It is a schematic diagram of the structure of an electronic device disclosed in an embodiment of the present application.

[0035] Description of reference numerals: 400 - electronic device; 401 - processor; 402 - communication bus; 403 - user interface; 404 - network interface; 405 - memory. DETAILED DESCRIPTION

[0036] In order to enable technicians in this field to better understand the technical solutions in this specification, the technical solutions in the embodiments of this specification will be clearly and completely described below in conjunction with the drawings in the embodiments of this specification. Obviously, the described embodiments are only part of the embodiments of this application, not all of the embodiments.

[0037] In the description of the embodiments of the present application, words such as "for example" or "for example" are used to indicate examples, illustrations or explanations. Any embodiment or design described as "for example" or "for example" in the embodiments of the present application should not be interpreted as being more preferred or more advantageous than other embodiments or designs. Specifically, the use of words such as "for example" or "for example" is intended to present related concepts in a specific way.

[0038] In the description of the embodiments of the present application, the meaning of the term "multiple" refers to two or more. For example, multiple systems refer to two or more systems, and multiple screen terminals refer to two or more screen terminals. In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the indicated technical features. Thus, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. The terms "include", "comprise", "have" and their variations all mean "including but not limited to", unless otherwise specifically emphasized.

[0039] The present application provides a method for controlling drug administration, referring to Figure 1 , Figure 1 This is a flow chart of a drug administration control method provided in an embodiment of the present application, comprising the following steps:

[0040] Step S101, sending a target drug administration instruction to the electronic analgesia pump to instruct the electronic analgesia pump to configure target drug administration parameters according to the target drug administration instruction;

[0041] Step S102, when the electronic analgesic pump administers medication to the target patient according to the target medication parameters, the medication information is recorded, and an information collection instruction is sent to the smart wearable device at the start medication time to instruct the smart wearable device to collect the body parameter information of the target patient, wherein the target patient wears the smart wearable device, and the medication information includes medication parameter information corresponding to multiple times, and the multiple times include the start medication time;

[0042] Step S103, detect whether there is any abnormality in the medication according to the current medication parameter information and the current body parameter information, and when it is determined that there is any abnormality in the medication, control the electronic analgesia pump to stop medication to the target patient, wherein the current medication parameter information is the medication parameter information included in the medication information and corresponding to the current moment, the current moment is any moment among multiple moments, and the current body parameter information is used to represent the body parameter information collected by the smart wearable device at the current moment.

[0043] The execution subject of the above steps may be a terminal, a control terminal, a device, or a controller, but is not limited thereto.

[0044] In the above embodiment, a target drug administration instruction is sent to the electronic analgesic pump, and the electronic analgesic pump configures the target drug administration parameters according to the target drug administration instruction. For example, the target drug administration parameters may include drug administration period, start drug administration time, stop drug administration time, preset total drug administration amount, and drug administration duration (or continuous infusion amount, or flow rate). The drug administration duration refers to the amount of medicine administered per unit time (such as per hour), such as how many milliliters / hour, or how many milligrams / hour. The target drug administration parameters may also include the maximum drug dose, etc.; in the process of administering the drug to the target patient according to the target drug administration parameters, the electronic analgesic pump records the drug administration information, that is, records the drug administration parameter information corresponding to different times, and sends an information collection instruction to the smart wearable device at the start drug administration time, so that the smart wearable device can collect the target patient's physical parameter information, such as , the body parameter information may include heart rate, blood pressure, body temperature, etc.; optionally, the drug administration information may be obtained in real time, or at a predetermined frequency (such as every few minutes or seconds), and the drug administration information may include the current continuous drug administration amount (or continuous infusion amount) of the electronic analgesic pump and the amount already injected, and the amount already injected indicates the amount of medicine that has been injected from the start of drug administration to the current moment; taking the control terminal to execute the above steps as an example, the terminal can obtain the body parameter information collected by the smart wearable device; then, based on the current drug administration parameter information and the current body parameter information, it is detected whether there is any abnormality in the drug administration of the electronic analgesic pump, the current drug administration parameter information is used to indicate the drug administration parameter information at the current moment, and the current body parameter information is used to indicate the body parameter information collected at the current moment, and when it is determined that there is an abnormality, the electronic analgesic pump is controlled to stop administering the drug to the target patient. The purpose of real-time monitoring of medication parameter information is achieved, and whether there is any abnormality in medication is determined in time in combination with the physical parameter information of the target patient, and the purpose of stopping medication in time when an abnormality is determined is achieved. This avoids the need for manual control of medication and the need to rely on manual labor to discover whether there is any abnormality in medication in related technologies, resulting in a low degree of intelligence and an inability to detect abnormalities in time. Therefore, the technical problem of low efficiency of medication control existing in related technologies is solved, and the effect of improving the efficiency of medication control is achieved.

[0045] Figure 2 This is an example diagram of an application scenario of drug administration control provided in an embodiment of the present application. The control terminal communicates with an electronic analgesia pump and a smart wearable device. The control terminal sends a target drug administration instruction to the electronic analgesia pump. The electronic analgesia pump generates drug administration information when administering drugs (or infusing) to the patient. The control terminal obtains the drug administration information from the electronic analgesia pump. The control terminal also sends an information collection instruction to the smart wearable device at the start of drug administration. The smart wearable device starts to collect the patient's body parameter information, and the control terminal obtains the body parameter information from the smart wearable device.

[0046] In an optional embodiment, detecting whether there is an abnormality in drug administration based on current drug administration parameter information and current body parameter information includes: judging whether the current drug administration parameter information matches the current body parameter information based on a preset standard parameter mapping table, wherein the standard parameter mapping table records the correspondence between the drug administration parameters and the body parameter reference ranges; when it is judged that the current drug administration parameter information does not match the current body parameter information, determining that there is an abnormality in drug administration; when it is judged that the current drug administration parameter information matches the current body parameter information, determining that there is no abnormality in drug administration.

[0047] In the above embodiment, the preset standard parameter mapping table records the correspondence between the medication parameters and the reference range of the body parameters. For example, the preset standard parameter mapping table records the continuous infusion volume and the corresponding heart rate range or blood pressure range (or other body parameter range). In practical applications, the standard body parameter reference range can be set for different medication parameters according to historical data to obtain a preset standard parameter mapping table; according to the standard parameter mapping table, it is determined whether the current medication parameter information matches the current body parameter information. When it is determined that they match, it is determined that there is no abnormality in the medication. On the contrary, when it is determined that they do not match, it is determined that there is an abnormality in the medication. The purpose of automatically determining whether there is an abnormality in the current medication situation based on the preset standard parameter mapping table is achieved.

[0048] In an optional embodiment, after determining that there is an abnormality in the medication, the method further includes: determining a target category to which the abnormality belongs based on current medication parameter information and current body parameter information.

[0049] In the above embodiment, after determining that there is an abnormality in drug administration, further, the target category to which the abnormality belongs can be determined based on the current drug administration parameter information and the current body parameter information, that is, the specific abnormality category can be determined. For example, the historical drug administration data and body parameter data of different patients in the previous drug administration (or infusion) process can be used to summarize multiple abnormal types, such as abnormal drug dosage in the body, abnormal needle blocking, abnormal loose needle, or other abnormalities, and then the abnormality category can be determined based on the current drug administration parameter information and the current body parameters.

[0050] In an optional embodiment, a target category to which an abnormality belongs is determined based on current medication parameter information and current body parameter information, including: inputting the current medication parameter information and the current body parameter information into a pre-trained anomaly detection model to obtain a target category, wherein the anomaly detection model is obtained in the following manner: training an original neural network model using a sample data packet set until a loss value between a predicted sample result output by the original neural network model and a predetermined actual sample result satisfies a preset convergence condition, terminating the training, and determining the original neural network model at the end of the training as an anomaly detection model, wherein each sample data packet in the sample data packet set includes medication parameter sample data and body parameter sample data, and the actual sample results corresponding to each sample data packet in the sample data packet set are used to represent the abnormal category of the sample data packet.

[0051] In the above embodiment, the current medication parameter information and the current body parameter information are detected using a pre-trained anomaly detection model to obtain a target category. The anomaly detection model is obtained by training the original neural network model using a sample data packet set, and the sample data packet set may include historical medication data and patient body parameter data. For example, the sample data set may include historical medication data and body parameter data of different patients in the previous medication (or infusion) process, as well as the final determined anomaly category. The original neural network model is trained using the sample data packet set. After the training is completed to obtain the anomaly detection model, the current medication parameter information and the current body parameter information can be input into the anomaly detection model to obtain the corresponding target category. The purpose of using the anomaly detection model to detect the target category to which the anomaly belongs is achieved, so that medical staff can handle the anomaly in a timely and effective manner.

[0052] In an optional embodiment, whether the current medication parameter information matches the current body parameter information is determined based on a preset standard parameter mapping table, including: determining a body parameter reference range corresponding to the current medication parameter information in the standard parameter mapping table; when the current body parameter information falls within the body parameter reference range, determining that the current medication parameter information matches the current body parameter information; when the current body parameter information does not fall within the body parameter reference range, determining that the current medication parameter information does not match the current body parameter information.

[0053] In the above embodiment, the body parameter reference range corresponding to the current medication parameter information is determined in the standard parameter mapping table. For example, if the current medication parameter information is the injected amount (or other medication parameter information), the standard body parameter reference range corresponding to the injected amount is searched in the standard parameter mapping table. If the current body parameter information belongs to the body parameter reference range, it is determined that the current medication parameter information matches the current body parameter information. If the current body parameter information does not belong to the body parameter reference range, it is determined that the current medication parameter information does not match the current body parameter information. The purpose of determining whether the current medication parameter information matches the current body parameter information based on the preset standard parameter mapping table is achieved.

[0054] In an optional embodiment, when it is determined that there is an abnormality in the drug administration, the electronic analgesia pump is controlled to stop administering the drug to the target patient, including: when it is determined that there is an abnormality in the drug administration, a stop drug administration instruction is sent to the electronic analgesia pump to instruct the electronic analgesia pump to stop administering the drug to the target patient, and an alarm message is issued.

[0055] In the above embodiment, when it is determined that there is an abnormality in the drug administration of the electronic analgesic pump, a stop drug administration instruction is sent to the electronic analgesic pump to control the electronic analgesic pump to stop administering the drug to the target patient, and to issue an alarm message. Taking the control terminal executing the above operation as an example, an alarm message can be issued on the control terminal. In actual applications, the electronic analgesic pump can also issue a warning message; that is, when an abnormality occurs, it can automatically stop drug administration and issue an alarm in time.

[0056] In an optional embodiment, the above method also includes: recording the stop time information when the electronic analgesia pump stops administering medication to the target patient, wherein when the amount injected by the electronic analgesia pump is greater than or equal to the preset total medication amount, the medication to the target patient is automatically stopped; and sending a stop collection instruction to the smart wearable device at the time corresponding to the stop time information to instruct the smart wearable device to stop collecting the target patient's physical parameter information.

[0057] In the above embodiment, when the amount of medicine injected by the electronic analgesia pump is greater than or equal to the preset total amount of medicine, the electronic analgesia pump automatically stops administering medicine to the target patient. The amount of medicine injected refers to the amount of medicine that the target patient has currently injected. At this time, the stop time information is recorded, and a stop collection instruction is sent to the smart wearable device at this time, that is, the smart wearable device is notified to stop collecting the physical parameter information of the target patient. For example, the electronic analgesia pump configures the drug administration parameters according to the target drug administration instruction, including the preset total amount of medicine. When administering medicine (or infusion) to the target patient, the electronic analgesia pump will count the amount of medicine injected in real time. When the amount of medicine injected reaches the preset total amount of medicine, the electronic analgesia pump will stop administering medicine immediately. Optionally, a prompt message can also be issued on the display screen of the electronic analgesia pump to prompt that the amount of medicine has reached the preset total amount of medicine.

[0058] In an optional embodiment, before sending the target drug administration instruction to the electronic analgesia pump, the above method also includes: receiving a target preset table to control the electronic analgesia pump to administer the drug according to the target preset table, wherein the target preset table includes the drug administration period, the start drug administration time, the stop drug administration time, the preset total drug administration amount, and the duration of drug administration.

[0059] In the above embodiment, a target pre-schedule is received, and the electronic analgesia pump is controlled to perform medication based on the target pre-schedule. The target pre-schedule includes medication time period, medication start time, medication stop time, preset medication total amount, and medication duration. For example, the target pre-schedule can be input into the control terminal in advance by medical staff. The control terminal can parse the corresponding medication parameters according to the target pre-schedule and send a target medication instruction to the electronic analgesia pump, that is, send a target medication instruction to the electronic analgesia pump based on the target pre-schedule.

[0060] The present application also provides a drug administration control system, such as Figure 3 As shown, Figure 3 This is a framework diagram of a drug administration control system provided by an embodiment of the present application, the system comprising: a control terminal, an electronic analgesia pump, and an intelligent wearable device, wherein the control terminal is respectively connected to the electronic analgesia pump and the intelligent wearable device for communication; the control terminal is used to send a target drug administration instruction to the electronic analgesia pump to instruct the electronic analgesia pump to configure the target drug administration parameters according to the target drug administration instruction; the electronic analgesia pump is used to respond to the target drug administration instruction issued by the control terminal, and control the drug administration to the target patient according to the target drug administration instruction; the control terminal is also used to record drug administration information when the electronic analgesia pump administers the drug to the target patient according to the target drug administration parameters, and send an information collection instruction to the intelligent wearable device at the start of drug administration to instruct the intelligent wearable device to collect the physical parameter information of the target patient, wherein the target patient A smart wearable device is worn, and the medication information includes medication parameter information corresponding to multiple moments, and the multiple moments include a starting medication moment; the smart wearable device is used to respond to an information collection instruction issued by a control terminal, collect body parameter information of a target patient, and send the body parameter information to the control terminal; the control terminal is also used to detect whether there is an abnormality in medication according to the current medication parameter information and the current body parameter information, and when it is determined that there is an abnormality in medication, control the electronic analgesia pump to stop medication to the target patient, wherein the current medication parameter information is the medication parameter information included in the medication information and corresponding to the current moment, the current moment is any one of the multiple moments, and the current body parameter information is used to represent the body parameter information collected by the smart wearable device at the current moment.

[0061] By adopting the above technical solution, the control terminal sends a target drug administration instruction to the electronic analgesia pump, and the electronic analgesia pump configures the target drug administration parameters according to the target drug administration instruction. For example, the target drug administration parameters may include the drug administration period, the start drug administration time, the stop drug administration time, the preset total drug administration amount, and the continuous drug administration amount (or continuous infusion amount, or flow rate). The continuous drug administration amount refers to the amount of medicine given per unit time (such as per hour), such as how many milliliters / hour, or how many milligrams / hour. The target drug administration parameters may also include the maximum drug dose, etc.; when the electronic analgesia pump administers the drug to the target patient according to the target drug administration parameters, the control terminal also obtains and records the drug administration information. The drug administration information at multiple times can be obtained, and the drug administration information can also be obtained in real time; the control terminal also sends an information collection instruction to the smart wearable device at the start drug administration time, so that the smart wearable device can collect the physical parameters of the target patient. information, and transmit the body parameter information to the control terminal; for example, the body parameter information may include heart rate, blood pressure, body temperature, etc.; optionally, the drug administration information may be obtained in real time, or at a predetermined frequency (such as every few minutes or seconds), and the drug administration information may include the current continuous drug administration amount (or continuous infusion amount) of the electronic analgesic pump and the amount already injected, and the amount already injected indicates the amount of medicine that has been injected from the start of drug administration to the current moment; taking the control terminal executing the above steps as an example, the terminal can obtain the body parameter information collected by the smart wearable device; in this way, the control terminal can detect whether there is an abnormality in drug administration based on the current drug administration parameter information and the current body parameter information, the current drug administration parameter information is used to indicate the drug administration parameter information at the current moment, and the current body parameter information is used to indicate the body parameter information collected at the current moment, and when it is determined that there is an abnormality, the electronic analgesic pump is controlled to stop drug administration. The purpose of real-time monitoring of medication parameter information is achieved, and whether there is any abnormality in medication is determined in time in combination with the physical parameter information of the target patient, and the purpose of stopping medication in time when an abnormality is determined is achieved. This avoids the need for manual control of medication and the need to rely on manual labor to discover whether there is any abnormality in medication in related technologies, resulting in a low degree of intelligence and an inability to detect abnormalities in time. Therefore, the technical problem of low efficiency of medication control existing in related technologies is solved, and the effect of improving the efficiency of medication control is achieved.

[0062] Optionally, upon receiving an adjustment instruction, the electronic analgesia pump adjusts the target drug administration parameters to obtain adjusted target drug administration parameters, and controls drug administration to the target patient according to the adjusted target drug administration parameters.

[0063] By adopting the above technical solution, the electronic analgesic pump can also adjust the target drug administration parameters according to the adjustment instruction, and administer the drug to the target patient according to the adjusted target drug administration parameters. Optionally, the adjustment instruction can be sent by the control terminal to the electronic analgesic pump, or it can be generated by the user triggering a button or key of the electronic analgesic pump, thus achieving the purpose of flexibly adjusting the drug administration according to the actual needs of different patients.

[0064] It should be noted that the above-described embodiments are only a part of the embodiments of the present application, rather than all the embodiments. The present application will be described in detail below in conjunction with specific embodiments.

[0065] The embodiment of the present application provides a narcotic analgesic medication warning method and system based on multi-terminal interaction, the system comprising a smart wearable device (such as a bracelet), an electronic analgesic pump and a control terminal; wherein the control terminal establishes communication connections with the smart wearable device and the electronic analgesic pump respectively; when administering analgesic medication, the patient needs to wear the smart wearable device.

[0066] The following is a description of the role and function of each device in the system:

[0067] An electronic analgesic pump is used to respond to a drug administration instruction issued by a control terminal, configure initial drug administration parameters according to the drug administration instruction, and respond to an adjustment instruction for the initial drug administration parameters to adjust the initial drug administration parameters to obtain target drug administration parameters; and control narcotic analgesic medication according to the target drug administration parameters; wherein the drug administration parameters at least include the total drug administration amount, the first drug administration amount, the continuous infusion amount, the self-controlled drug administration amount, the limit amount and the lock time, etc.

[0068] The control terminal is used to record the time point when the electronic analgesia pump administers the drug according to the target drug administration parameters, and send an information collection instruction to the smart wearable device at the drug administration time point; and the control terminal is also used to record the stop time point when the electronic analgesia pump stops administering the drug according to the target drug administration parameters, and send an information stop collection instruction to the smart wearable device at the stop time point.

[0069] The intelligent wearable device is used to respond to the information collection instruction to collect the patient's physical parameter information, and transmit the physical parameter information back to the control terminal in real time until the information stop collection instruction is detected.

[0070] The control terminal is also used to associate the drug administration parameters of the electronic analgesic pump and the patient's body parameters at each time point, and compare the drug administration parameters and body parameters at each time point with the pre-set standard parameter interval mapping range to detect whether an abnormal condition occurs. If an abnormality occurs, the abnormal time point, the corresponding drug administration parameters and body parameters are recorded; and the abnormal time point, the corresponding drug administration parameters and body parameters are input into a pre-trained abnormality detection model to obtain an abnormality category output by the abnormality detection model; wherein the abnormal category at least includes abnormal amount of drug entering the patient's body, needle blockage, loose needles, etc.

[0071] The above description is based on the example of narcotic analgesics. The early warning method (or medication control method) of the embodiment of the present application is also applicable to the medication control of other drugs.

[0072] The embodiments of the present application are described in detail below.

[0073] (1) Obtaining hospital two-dimensional layout map data, wherein the hospital two-dimensional layout map data is marked with anesthesia and analgesia area distribution data;

[0074] (2) Conduct 3D simulation modeling based on the 2D layout map data of the hospital;

[0075] (3) Based on the anesthesia and analgesia regional distribution data, calculate the anesthesia and analgesia regional distribution index parameters (regional area, ratio of regional area to total hospital area, degree of regional distribution dispersion, etc.); determine the deployment indicators of control terminals and smart wearable devices that match the anesthesia and analgesia regional distribution index parameters (deployment location, deployment quantity, deployed device parameters, etc.);

[0076] (4) Import the deployment indicators into the three-dimensional simulation model, and further obtain the hospital's historical anesthesia data (the number of patients undergoing anesthesia, the time period for each patient to undergo anesthesia, etc.) and import them into the three-dimensional simulation model. Combined with the historical anesthesia data, the deployment indicators are evaluated. If the indicator evaluation passes, the smart wearable devices and control terminals are deployed according to the deployment indicators. If the indicator evaluation fails, the deployment indicators are adjusted, and the three-dimensional simulation is re-performed based on the adjusted deployment indicators and the hospital's historical anesthesia data until the indicator evaluation passes.

[0077] (5) The anesthesia and analgesia area can be divided into multiple anesthesia and analgesia sub-areas, each of which corresponds to a control terminal, and the control terminal is used to establish a communication connection with the electronic analgesia pump in the anesthesia and analgesia sub-area and the smart wearable device in the anesthesia and analgesia sub-area;

[0078] (6) For each anesthesia and analgesia sub-area, the corresponding medical staff can input the anesthesia and analgesia medication pre-schedule table of the sub-area into the control terminal of the sub-area in advance, so that the control terminal can perform field analysis and determine the medication time period and medication parameters corresponding to the medication time period;

[0079] (7) The control terminal sends a dosing instruction to the corresponding electronic analgesic pump during the dosing period, so that the electronic analgesic pump configures the initial dosing parameters according to the dosing instruction and displays the initial dosing parameters on the display screen. If an adjustment instruction for the initial dosing parameters is detected (the medical staff operates the electronic analgesic pump to trigger the adjustment), the initial dosing parameters are adjusted to obtain the target dosing parameters, and then the narcotic analgesic medication is controlled according to the target dosing parameters;

[0080] (8) In the process of controlling the use of narcotic analgesics according to the target drug administration parameters, the control terminal can send a body parameter collection instruction to the smart wearable device corresponding to the corresponding patient to synchronously collect body parameter information;

[0081] (9) The control terminal can detect whether there is an abnormality by combining the medication time, medication parameters, physical parameters, corresponding patient parameters (patient age, gender, medical history, etc.), a pre-set standard parameter interval mapping range, and a pre-trained abnormality detection model (such as a multi-classification model);

[0082] (10) If an abnormality is detected, the corresponding prompt information is output according to the abnormality category.

[0083] In the embodiment of the present application, a control terminal and an intelligent wearable device are introduced to establish a multi-terminal interactive system with the existing electronic analgesic pump, and the optimal equipment deployment parameters are automatically determined in combination with the regional distribution of the hospital. After the equipment is deployed, the narcotic analgesic medication parameters can be managed in batches through the control terminal in the sub-area, and the patient's physical parameters can be collected in combination with the intelligent wearable device to perform real-time abnormal judgment and automatically output abnormal warnings, thereby improving the control accuracy and intelligence of narcotic analgesic drugs.

[0084] Through the description of the above implementation methods, those skilled in the art can clearly understand that the method according to the above embodiment can be implemented by means of software plus a necessary general hardware platform, and of course by hardware, but in many cases the former is a better implementation method. Based on this understanding, the technical solution of the present application, or the part that contributes to the prior art, can be embodied in the form of a software product, which is stored in a storage medium (such as ROM / RAM, magnetic disk, optical disk), and includes a number of instructions for a terminal device (which can be a mobile phone, computer, server, or network device, etc.) to execute the methods described in each embodiment of the present application.

[0085] It should be noted that: when the device provided in the above embodiment realizes its function, only the division of the above functional modules is used as an example. In actual application, the above functions can be assigned to different functional modules as needed, that is, the internal structure of the device is divided into different functional modules to complete all or part of the functions described above. In addition, the device and method embodiments provided in the above embodiment belong to the same concept, and the specific implementation process is detailed in the method embodiment, which will not be repeated here.

[0086] The present application also provides a computer-readable storage medium, in which instructions are stored. When the instructions are executed, any one of the method steps described above is executed.

[0087] In an exemplary embodiment, the computer-readable storage medium may include, but is not limited to, various media that can store computer programs, such as a USB flash drive, a read-only memory (ROM), a random access memory (RAM), a mobile hard disk, a magnetic disk or an optical disk.

[0088] The present application also discloses an electronic device. Figure 4 As shown, Figure 4 The electronic device 400 may include: at least one processor 401 , at least one network interface 404 , a user interface 403 , a memory 405 , and at least one communication bus 402 .

[0089] The communication bus 402 is used to realize the connection and communication between these components.

[0090] The user interface 403 may include a display screen (Display) and a camera (Camera). Optionally, the user interface 403 may also include a standard wired interface and a wireless interface.

[0091] The network interface 404 may optionally include a standard wired interface or a wireless interface (such as a WI-FI interface).

[0092] Among them, the processor 401 may include one or more processing cores. The processor 401 uses various interfaces and lines to connect various parts of the entire electronic device (such as a server), and executes various functions of the server and processes data by running or executing instructions, programs, code sets or instruction sets stored in the memory 405, and calling data stored in the memory 405. Optionally, the processor 401 can be implemented in at least one hardware form of digital signal processing (Digital Signal Processing, DSP), field programmable gate array (Field-Programmable Gate Array, FPGA), and programmable logic array (Programmable Logic Array, PLA). The processor 401 can integrate one or a combination of a central processing unit (Central Processing Unit, CPU), a graphics processing unit (Graphics Processing Unit, GPU) and a modem. Among them, the CPU mainly processes the operating system, user interface and application programs; the GPU is responsible for rendering and drawing the content to be displayed on the display screen; the modem is used to process wireless communications. It can be understood that the above-mentioned modem may not be integrated into the processor 401, and it can be implemented separately through a chip.

[0093] Among them, the memory 405 may include a random access memory (Random Access Memory, RAM) and may also include a read-only memory (Read-Only Memory). Optionally, the memory 405 includes a non-transitory computer-readable storage medium. The memory 405 can be used to store instructions, programs, codes, code sets or instruction sets. The memory 405 may include a program storage area and a data storage area, wherein the program storage area may store instructions for implementing an operating system, instructions for at least one function (such as a touch function, a sound playback function, an image playback function, etc.), instructions for implementing the above-mentioned various method embodiments, etc.; the data storage area may store data involved in the above-mentioned various method embodiments, etc. The memory 405 may optionally also be at least one storage device located away from the aforementioned processor 401. Refer to Figure 4 , the memory 405 as a computer storage medium may include an operating system, a network communication module, a user interface module and an application program of a drug administration control method.

[0094] exist Figure 4In the electronic device 400 shown, the user interface 403 is mainly used to provide an input interface for the user and obtain the data input by the user; and the processor 401 can be used to call an application program of a medication control method stored in the memory 405, and when executed by one or more processors 401, the electronic device 400 executes one or more of the methods described in the above embodiments. It should be noted that for the aforementioned method embodiments, for the sake of simple description, they are all expressed as a series of action combinations, but those skilled in the art should know that the present application is not limited to the described order of actions, because according to the present application, certain steps can be performed in other orders or simultaneously. Secondly, those skilled in the art should also know that the embodiments described in the specification are all preferred embodiments, and the actions and modules involved are not necessarily required for the present application.

[0095] In the above embodiments, the description of each embodiment has its own emphasis. For parts that are not described in detail in a certain embodiment, reference can be made to the relevant descriptions of other embodiments.

[0096] In the several embodiments provided in this application, it should be understood that the disclosed devices can be implemented in other ways. For example, the device embodiments described above are only schematic, such as the division of units, which is only a logical function division. There may be other division methods in actual implementation, such as multiple units or components can be combined or integrated into another system, or some features can be ignored or not executed. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be through some service interfaces, and the indirect coupling or communication connection of devices or units can be electrical or other forms.

[0097] The units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, that is, they may be located in one place or distributed on multiple network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of this embodiment.

[0098] In addition, each functional unit in each embodiment of the present application may be integrated into one processing unit, or each unit may exist physically separately, or two or more units may be integrated into one unit. The above-mentioned integrated unit may be implemented in the form of hardware or in the form of software functional units.

[0099] If the integrated unit is implemented in the form of a software functional unit and sold or used as an independent product, it can be stored in a computer-readable memory. Based on this understanding, the technical solution of the present application, or the part that contributes to the prior art, or all or part of the technical solution can be embodied in the form of a software product, which is stored in a memory and includes several instructions for a computer device (which can be a personal computer, server or network device, etc.) to execute all or part of the steps of the various embodiments of the present application. The aforementioned memory includes: various media that can store program codes, such as USB flash drives, mobile hard drives, magnetic disks or optical disks.

[0100] The above is only an exemplary embodiment of the present disclosure and cannot be used to limit the scope of the present disclosure. That is, any equivalent changes and modifications made according to the teachings of the present disclosure are still within the scope of the present disclosure. After considering the disclosure of the specification and the truth of practice, those skilled in the art will easily think of other embodiments of the present disclosure.

[0101] This application is intended to cover any modifications, uses or adaptations of the present disclosure, which follow the general principles of the present disclosure and include common knowledge or customary technical means in the technical field not recorded in the present disclosure.

Claims

1. A drug administration control system, characterized in that: include: Control terminal, electronic analgesia pump, smart wearable device, among which, The control terminal is respectively connected to the electronic analgesia pump and the smart wearable device for communication; The control terminal is used to send a target drug administration instruction to the electronic analgesia pump to instruct the electronic analgesia pump to configure target drug administration parameters according to the target drug administration instruction; The electronic analgesia pump is used to respond to the target medication instruction issued by the control terminal, and control medication to the target patient according to the target medication instruction; The control terminal is also used to record medication information when the electronic analgesic pump administers medication to the target patient according to the target medication parameters, and to send an information collection instruction to the smart wearable device at the start of medication to instruct the smart wearable device to collect the physical parameter information of the target patient, wherein the target patient wears the smart wearable device, and the medication information includes medication parameter information corresponding to multiple moments, and the multiple moments include the start of medication. The smart wearable device is used to respond to the information collection instruction issued by the control terminal, collect the physical parameter information of the target patient, and send the physical parameter information to the control terminal; The control terminal is also used to detect whether there is an abnormality in the drug administration according to the current drug administration parameter information and the current body parameter information, and to control the electronic analgesia pump to stop administering the drug to the target patient when it is determined that there is an abnormality in the drug administration, wherein the current drug administration parameter information is the drug administration parameter information corresponding to the current moment included in the drug administration information, the current moment is any moment among the multiple moments, and the current body parameter information is used to indicate the body parameter information collected by the smart wearable device at the current moment; The control terminal is also used to detect whether there is any abnormality in drug administration by the following methods: Determining whether the current medication parameter information matches the current body parameter information based on a preset standard parameter mapping table, wherein the standard parameter mapping table records the corresponding relationship between medication parameters and body parameter reference ranges; In the case where it is determined that the current medication parameter information does not match the current body parameter information, determining that medication is abnormal; When it is determined that the current medication parameter information matches the current body parameter information, it is determined that there is no abnormality in the medication.

2. The system according to claim 1, characterized in that When receiving the adjustment instruction, the electronic analgesia pump adjusts the target drug administration parameter to obtain the adjusted target drug administration parameter, and controls drug administration to the target patient according to the adjusted target drug administration parameter.

3. The system according to claim 1, characterized in that The control terminal is further used to: after determining that there is an abnormality in the medication, determine the target category to which the abnormality belongs according to the current medication parameter information and the current body parameter information.

4. The system according to claim 3, characterized in that The control terminal is used to determine the target category to which the anomaly belongs in the following manner, including: The current medication parameter information and the current body parameter information are input into a pre-trained anomaly detection model to obtain the target category, wherein the anomaly detection model is obtained in the following manner: The original neural network model is trained using a set of sample data packets until the loss value between the predicted sample results output by the original neural network model and the predetermined actual sample results meets a preset convergence condition, and the training is terminated. The original neural network model at the end of the training is determined as the anomaly detection model, wherein each sample data packet in the set of sample data packets includes medication parameter sample data and body parameter sample data, and the actual sample results corresponding to each sample data packet in the set of sample data packets are used to represent the anomaly category of the sample data packet.

5. The system according to claim 1, characterized in that The control terminal is used to determine whether the current medication parameter information matches the current body parameter information in the following manner, including: Determining a reference range of a body parameter corresponding to the current medication parameter information in the standard parameter mapping table; When the current body parameter information is within the body parameter reference range, determining that the current medication parameter information matches the current body parameter information; When the current body parameter information does not fall within the body parameter reference range, it is determined that the current medication parameter information does not match the current body parameter information.

6. The system according to claim 1, characterized in that When it is determined that there is an abnormality in the drug administration, the control terminal is used to control the electronic analgesia pump to stop administering the drug to the target patient in the following manners, including: When it is determined that there is an abnormality in the drug administration, a stop drug administration instruction is sent to the electronic analgesia pump to instruct the electronic analgesia pump to stop administering the drug to the target patient and to issue an alarm message.

7. The system according to claim 1, characterized in that The control terminal is also used to perform the following operations: In the case where the electronic analgesia pump stops administering medication to the target patient, recording the stop time information, wherein the electronic analgesia pump automatically stops administering medication to the target patient when the amount of medication already injected by the electronic analgesia pump is greater than or equal to the preset total amount of medication; At the time corresponding to the stop time information, a stop collection instruction is sent to the smart wearable device to instruct the smart wearable device to stop collecting the physical parameter information of the target patient.

8. The system according to claim 1, characterized in that The control terminal is also used to perform the following operations before sending the target drug administration instruction to the electronic analgesia pump: Receive a target pre-schedule to control the electronic analgesia pump to administer medication according to the target pre-schedule, wherein the target pre-schedule includes medication time period, medication start time, medication stop time, preset medication total amount, and medication duration.

Images